Chemed Corp (CHE) is now in the Undervalued zone, suggesting that its current forward PE ratio of 16.91 is considered Undervalued compared with the five-year average of 23.77. The fair price of Chemed Corp (CHE) is between 510.34 to 607.39 according to relative valuation method. Compared to the current price of 421.40 USD , Chemed Corp By Undervalued By 17.43%.

Relative Value

Fair Zone

510.34-607.39

Current Price：421.40

17.43%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Chemed Corp (CHE) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Chemed Corp (CHE) has a current Price-to-Book (P/B) ratio of 5.55. Compared to its 3-year average P/B ratio of 7.38, the current P/B ratio is approximately -24.74% higher. Relative to its 5-year average P/B ratio of 8.36, the current P/B ratio is about -33.55% higher. Chemed Corp (CHE) has a Forward Free Cash Flow (FCF) yield of approximately 6.03%. Compared to its 3-year average FCF yield of 3.77%, the current FCF yield is approximately 60.08% lower. Relative to its 5-year average FCF yield of 3.84%, the current FCF yield is about 57.04% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CHE competitors is 0.85, providing a benchmark for relative valuation. Chemed Corp Corp (CHE.N) exhibits a P/S ratio of 2.25, which is 164.86% above the industry average. Given its robust revenue growth of -0.10%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CHE increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CHE in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CHE currently overvalued or undervalued?

What is Chemed Corp (CHE) fair value?

CHE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Chemed Corp (CHE) is between 510.34 to 607.39 according to relative valuation method.

How does CHE's valuation metrics compare to the industry average?

The average P/S ratio for CHE's competitors is 0.85, providing a benchmark for relative valuation. Chemed Corp Corp (CHE) exhibits a P/S ratio of 2.25, which is 164.86% above the industry average. Given its robust revenue growth of -0.10%, this premium appears unsustainable.

What is the current P/B ratio for Chemed Corp (CHE) as of Mar 03 2026?

As of Mar 03 2026, Chemed Corp (CHE) has a P/B ratio of 5.55. This indicates that the market values CHE at 5.55 times its book value.

What is the current FCF Yield for Chemed Corp (CHE) as of Mar 03 2026?

As of Mar 03 2026, Chemed Corp (CHE) has a FCF Yield of 6.03%. This means that for every dollar of Chemed Corp's market capitalization, the company generates 6.03 cents in free cash flow.

What is the current Forward P/E ratio for Chemed Corp (CHE) as of Mar 03 2026?

As of Mar 03 2026, Chemed Corp (CHE) has a Forward P/E ratio of 16.91. This means the market is willing to pay $16.91 for every dollar of Chemed Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Chemed Corp (CHE) as of Mar 03 2026?

As of Mar 03 2026, Chemed Corp (CHE) has a Forward P/S ratio of 2.25. This means the market is valuing CHE at $2.25 for every dollar of expected revenue over the next 12 months.

CHE Valuation